secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bioventus Inc. (BVS)
CIK:        0001665988
Form:       8-K
Filed at:   2022-12-07T23:59:59+00:00
Accession:  0001628280-22-031531
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 2.05
LLM model:  deepseek-v4-flash:cloud@v2

Bioventus announces restructuring; expects $4-5M pre-tax costs, $9-10M annual savings
--------------------------------------------------------------------------------

- Restructuring announced Dec 6, 2022 to align cost structure and improve profitability and cash flow.
- Pre-tax costs of $4-5M: $3-4M employee severance/benefits, $1M third-party costs. All cash costs.
- Restructuring expected to be completed by end of 2023.
- Expected annualized cost savings of $9-10M upon completion.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1665988/000162828022031531/0001628280-22-031531-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1665988/000162828022031531/bvs-20221207.htm
  HTML page:      https://secwatch.observer/filing/0001628280-22-031531

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer